We are live on ! Find out more
DDC

DF Dent & Co Portfolio holdings

AUM $5.22B
1-Year Est. Return 2.07%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+2.07%
3 Year Est. Return
+40.35%
5 Year Est. Return
+39.43%
10 Year Est. Return
+332.93%
AUM
$6.69B
AUM Growth
+$218M
Cap. Flow
-$199M
Cap. Flow %
-2.98%
Top 10 Hldgs %
30.81%
Holding
255
New
12
Increased
78
Reduced
125
Closed
16

Top Buys

Rank Stock Value
1
DAVA icon
Endava
DAVA
+$40.1M
2
EW icon
Edwards Lifesciences
EW
+$34M
3
SITE icon
SiteOne Landscape Supply
SITE
+$22.2M
4
WNS
WNS Holdings
WNS
+$19.4M
5
WST icon
West Pharmaceutical
WST
+$18.3M

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$57M
2
WSC icon
WillScot Mobile Mini Holdings
WSC
+$39.2M
3
CSGP icon
CoStar Group
CSGP
+$34.9M
4
AZTA icon
Azenta
AZTA
+$34.4M
5
ISRG icon
Intuitive Surgical
ISRG
+$33.7M

Sector Composition

Rank Sector Weight
1 Healthcare 21.97%
2 Industrials 19.77%
3 Technology 18.44%
4 Financials 13.97%
5 Real Estate 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHWY icon
51
Chewy
CHWY
$8.57B
$29.8M 0.45%
804,716
-22,205
-3% -$865K
PRO
52
DELISTED
PROS Holdings
PRO
$26.4M 0.39%
1,087,353
-698,115
-39% -$17.1M
ROP icon
53
Roper Technologies
ROP
$36.6B
$22.4M 0.33%
51,819
+73
+0.1% +$30.1K
PLOW icon
54
Douglas Dynamics
PLOW
$1.03B
$22.3M 0.33%
616,054
-22,070
-3% -$778K
PG icon
55
Procter & Gamble
PG
$349B
$19.5M 0.29%
128,698
-6,254
-5% -$877K
W icon
56
Wayfair
W
$11.8B
$19.3M 0.29%
586,444
-15,753
-3% -$550K
MEDP icon
57
Medpace
MEDP
$15.4B
$18.3M 0.27%
86,036
-14,791
-15% -$2.96M
WST icon
58
West Pharmaceutical
WST
$25.3B
$18.2M 0.27%
+77,151
New +$18.3M
NOVT icon
59
Novanta
NOVT
$5.3B
$18.1M 0.27%
133,387
-2,210
-2% -$309K
EXPO icon
60
Exponent
EXPO
$3.05B
$17.4M 0.26%
175,753
-4,899
-3% -$476K
HLNE icon
61
Hamilton Lane
HLNE
$3.75B
$17.3M 0.26%
271,466
-10,214
-4% -$679K
APPF icon
62
AppFolio
APPF
$6.35B
$16.8M 0.25%
+159,126
New +$17.7M
HQY icon
63
HealthEquity
HQY
$8.17B
$14.4M 0.21%
233,086
-51,184
-18% -$3.44M
RGEN icon
64
Repligen
RGEN
$8.31B
$13.7M 0.2%
80,909
-2,814
-3% -$510K
JBTM
65
JBT Marel
JBTM
$6.98B
$13M 0.19%
142,514
-9,288
-6% -$850K
KNSL icon
66
Kinsale Capital Group
KNSL
$7.93B
$12.9M 0.19%
49,342
-10,832
-18% -$3.12M
KIDS icon
67
OrthoPediatrics
KIDS
$493M
$12.8M 0.19%
321,103
-79,936
-20% -$3.33M
ABCM
68
DELISTED
Abcam PLC
ABCM
$11.9M 0.18%
762,781
-50,744
-6% -$793K
MANH icon
69
Manhattan Associates
MANH
$9.66B
$11.8M 0.18%
97,156
+16,701
+21% +$2.05M
ATRI
70
DELISTED
Atrion Corp
ATRI
$11.7M 0.18%
20,994
+1,657
+9% +$1M
AAPL icon
71
Apple
AAPL
$4.9T
$11.6M 0.17%
88,995
-7,888
-8% -$1.13M
JNJ icon
72
Johnson & Johnson
JNJ
$609B
$11.2M 0.17%
63,274
+465
+0.7% +$80.3K
WDFC icon
73
WD-40
WDFC
$3.31B
$11.1M 0.17%
68,996
+14,031
+26% +$2.34M
TRUP icon
74
Trupanion
TRUP
$1.16B
$10.9M 0.16%
230,194
-13,578
-6% -$707K
TROW icon
75
T. Rowe Price
TROW
$25.1B
$10.7M 0.16%
98,007
+1,375
+1% +$156K
1 2
3
4 5

Similar funds

KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.22B AUM 17.11% 1-Year Est. Return
AUB
Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
FMWA
Forvis Mazars Wealth Advisors Springfield, Missouri $5.27B AUM 18.06% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.28B AUM 23.15% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return

DF Dent & Co's Q4 2022 Portfolio in Review

As of Q4 2022, DF Dent & Co held 255 positions worth $6.69B, up 3.4% from $6.47B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

DF Dent & Co's Q4 2022 filing shows 12 new, 78 increased, 125 reduced and 16 closed positions. Its largest new stake was West Pharmaceutical: 77,151 shares worth $18.2M. The largest sale was Idexx Laboratories, an estimated $57M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.

  • DF Dent & Co's largest Q4 2022 buy was West Pharmaceutical: 77,151 shares worth $18.2M.
  • DF Dent & Co added most to Endava in Q4 2022, an estimated $40.1M increase.
  • DF Dent & Co's biggest Q4 2022 reduction was Idexx Laboratories, cutting an estimated $57M.
  • DF Dent & Co fully exited IAA, Inc. Common Stock in Q4 2022, selling an estimated $12.6M.
  • DF Dent & Co's ten largest holdings make up 31% of its $6.69B portfolio in Q4 2022.
  • DF Dent & Co opened 12 new positions and closed 16 in Q4 2022.
  • DF Dent & Co's portfolio value rose 3.4% quarter-over-quarter to $6.69B.

Based on DF Dent & Co's 13F filing for Q4 2022, filed 15 Feb 2023.